Authors' reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gøtzsche, and Barber and colleagues
- PMID: 25301799
- DOI: 10.1136/bmj.g5722
Authors' reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gøtzsche, and Barber and colleagues
Comment on
-
Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study.BMJ. 2014 Jun 18;348:g3596. doi: 10.1136/bmj.g3596. BMJ. 2014. PMID: 24942789 Free PMC article.
-
Antidepressants increase, rather than decrease, risk of suicidal behaviours in younger patients.BMJ. 2014 Oct 9;349:g5626. doi: 10.1136/bmj.g5626. BMJ. 2014. PMID: 25300283 No abstract available.
-
Study of study of changes in antidepressant use after FDA warnings is not reliable.BMJ. 2014 Oct 9;349:g5623. doi: 10.1136/bmj.g5623. BMJ. 2014. PMID: 25300434 No abstract available.
-
Link between FDA antidepressant warnings and increased suicide attempts in young people is questionable.BMJ. 2014 Oct 9;349:g5614. doi: 10.1136/bmj.g5614. BMJ. 2014. PMID: 25301267 Free PMC article. No abstract available.
-
Study findings on FDA antidepressant warnings and suicide attempts in young people: a false alarm?BMJ. 2014 Oct 9;349:g5645. doi: 10.1136/bmj.g5645. BMJ. 2014. PMID: 25301785 No abstract available.
-
Impossible to draw meaningful conclusions from study of changes in antidepressant use after FDA warnings.BMJ. 2014 Oct 9;349:g5643. doi: 10.1136/bmj.g5643. BMJ. 2014. PMID: 25301791 No abstract available.
-
Proxy for suicide attempts was inappropriate in study of changes in antidepressant use after FDA warnings.BMJ. 2014 Oct 9;349:g5644. doi: 10.1136/bmj.g5644. BMJ. 2014. PMID: 25301794 No abstract available.
-
More data needed to interpret link between suicide and FDA warning on antidepressants.BMJ. 2014 Oct 9;349:g5616. doi: 10.1136/bmj.g5616. BMJ. 2014. PMID: 25301797 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical